Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • 629-A A safety and feasibility...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

629-A A safety and feasibility study of the oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Shubham Pant, Cullen Taniguchi, Ethan Ludmir, Vincent Bernard, Sonal Noticewala, Eric Perez Perez, Ching Wei Tzeng
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours
    by: Mark Lythgoe, et al.
    Published: (2020-11-01)
  • 283 Safety and efficacy signals in the complete phase I study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors (ICIs)
    by: Alexander Stevenson, et al.
    Published: (2020-11-01)
  • Functions and regulation of the MRX complex at DNA double-strand breaks
    by: Elisa Gobbini, et al.
    Published: (2016-07-01)
  • Safety Evaluation of Contezolid (MRX-I) Versus Linezolid in Sprague-Dawley Rats
    by: Liping Wei, et al.
    Published: (2025-05-01)
  • Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
    by: Shan. Gao, et al.
    Published: (2023-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs